Intrinsic Value of S&P & Nasdaq Contact Us

Sonnet BioTherapeutics Holdings, Inc. SONN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sonnet BioTherapeutics Holdings, Inc. (SONN) has 20 known insider and institutional holders on record. The largest holder is Markey John with 186,430 shares. Other notable holders include PALISADES MASTER FUND LP and SPITCAUFSKY LARRY.

SONN Insider Ownership

Top Holder
Markey John
186,430 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Markey John 10 Percent Owner 186,430 2023-09-07
100%
2 Palisades Master Fund Lp 10 Percent Owner 137,125 2008-08-14
74%
3 Spitcaufsky Larry 10 Percent Owner 41,480 2019-05-23
22%
4 Johnson Keith J Director 38,637 2019-05-14
21%
5 Page Russell Jacob Director 26,971 2019-05-14
14%
6 Kraut Gregory Evan Director 25,394 2017-12-19
14%
7 Corbman Brian Director 25,000 2005-10-27
13%
8 Block William A Director 25,000 2005-10-27
13%
9 Rugg Terence Anthony Chief Medical Officer 21,314 2020-07-02
11%
10 Kiefer Neil G Director 21,304 2019-05-06
11%
11 Carroll J Michael Director 20,500 2016-09-23
11%
12 Adams Richard Officer 17,246 2019-05-15
9%
13 Mohan Pankaj Chairman, President and CEO 14,987 2024-12-05
8%
14 Wagoner J Eric Director 14,561 2019-07-02
8%
15 Pruitt Michael D CEO, Chairman 10,223 2020-03-24
5%
16 Harkleroad Patrick Clay Chief Financial Officer 5,000 2019-05-06
3%
17 Glick Frederick L President 4,000 2020-03-24
2%
18 Moskowitz Paul I Director 3,100 2015-08-03
2%
19 Rao Raghu Director 2,356 2024-12-05
1%
20 Cini John K. Chief Scientific Officer 2,116 2024-12-05
1%

No ownership data available for SONN.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message